'Our legacy matters': Merck maps out Keytruda kingdom while spotlighting advances in vaccines, hospital care
“You can for the moment stop taking notes. You can put down your pens and your pad. I have no slides. I have no substantive data. I have no pitch.”
So began Roger Perlmutter’s brief appearance onstage at Merck’s first investor day in five years, where he dived into the company’s history dating back to 1933. The first employees at Merck Research Laboratories, handpicked by founder George W. Merck, were critical to Merck’s ability to achieve clinical and commercial success.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.